$ORGO
Organogenesis Holdings Inc. Stock $orgo

$orgo Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-K Financial Statement

#000119312521082849 Filed on March 16, 2021

Income Statement

Concept	2020 Q4	2020	2019 Q4
Revenue	$106.8M	$338.3M	$74.60M
YoY Change	43.16%	29.63%	17.3%
Cost Of Revenue	$25.50M	$87.32M	$20.40M
YoY Change	25.0%	14.97%	16.5%
Gross Profit	$81.30M	$251.0M	$54.30M
YoY Change	49.72%	35.64%	17.82%
Gross Profit Margin	76.12%	74.19%	72.79%
Selling, General & Admin	$53.20M	$203.5M	$52.40M
YoY Change	1.53%	1.9%	10.37%
% of Gross Profit	65.44%	81.07%	96.5%
Research & Development	$6.300M	$20.09M	$3.600M
YoY Change	75.0%	35.73%	16.47%
% of Gross Profit	7.75%	8.0%	6.63%
Depreciation & Amortization	$2.200M	$3.723M	$2.350M
YoY Change	-6.38%	9.89%	-66.33%
% of Gross Profit	2.71%	1.48%	4.33%
Operating Expenses	$59.50M	$223.6M	$56.00M
YoY Change	6.25%	4.23%	10.74%
Operating Profit	$21.80M	$27.42M	-$1.700M
YoY Change	-1382.35%	-193.06%	-62.05%
Interest Expense	-$2.900M	$11.28M	-$2.600M
YoY Change	11.54%	25.38%	-197.63%
% of Operating Profit	-13.3%	41.14%
Other Income/Expense, Net	$0.00	-$8.936M	$0.00
YoY Change		-17.6%	-100.0%
Pretax Income	$18.90M	$18.48M	-$4.400M
YoY Change	-529.55%	-145.85%	-52.45%
Income Tax	$400.0K	$530.0K	$0.00
% Of Pretax Income	2.12%	2.87%
Net Earnings	$18.50M	$17.95M	-$4.400M
YoY Change	-520.45%	-144.37%	-52.46%
Net Earnings / Revenue	17.32%	5.31%	-5.9%
Basic Earnings Per Share		$0.17
Diluted Earnings Per Share	$141.0K	$0.16	-$44.99K
COMMON SHARES
Basic Shares Outstanding	107.8M	107.7M	94.74M
Diluted Shares Outstanding		111.4M

Balance Sheet

Concept	2020 Q4	2020	2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$84.40M	$84.40M	$60.20M
YoY Change	40.2%	40.2%	182.63%
Cash & Equivalents	$84.81M		$60.37M
Short-Term Investments
Other Short-Term Assets	$5.300M	$5.300M	$3.200M
YoY Change	65.63%	65.63%	33.33%
Inventory	$27.80M	$27.80M	$22.92M
Prepaid Expenses	$4.935M		$2.953M
Receivables	$56.80M	$56.80M	$39.36M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$174.3M	$174.3M	$125.6M
YoY Change	38.81%	38.77%	76.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$60.07M	$60.10M	$47.18M
YoY Change	27.31%	27.33%	19.08%
Goodwill	$28.77M		$25.54M
YoY Change	12.66%		0.0%
Intangibles	$30.62M		$20.80M
YoY Change	47.24%		-20.29%
Long-Term Investments
YoY Change
Other Assets	$670.0K	$700.0K	$884.0K
YoY Change	-24.21%	-30.0%	52.68%
Total Long-Term Assets	$120.2M	$120.2M	$95.09M
YoY Change	26.36%	26.39%	2.74%
TOTAL ASSETS
Total Short-Term Assets	$174.3M	$174.3M	$125.6M
Total Long-Term Assets	$120.2M	$120.2M	$95.09M
Total Assets	$294.5M	$294.5M	$220.7M
YoY Change	33.44%	33.44%	34.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$23.38M	$23.40M	$28.39M
YoY Change	-17.63%	-17.61%	48.12%
Accrued Expenses	$23.97M	$24.00M	$23.45M
YoY Change	2.23%	2.13%	15.02%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$20.30M	$20.30M	$3.100M
YoY Change	554.84%	554.84%	-58.67%
Total Short-Term Liabilities	$68.22M	$68.20M	$59.89M
YoY Change	13.9%	13.86%	6.77%
LONG-TERM LIABILITIES
Long-Term Debt	$64.50M	$64.50M	$49.63M
YoY Change	29.95%	-33.85%	0.88%
Other Long-Term Liabilities	$7.971M	$15.70M	$6.649M
YoY Change	19.88%	103.9%	12.11%
Total Long-Term Liabilities	$7.971M	$80.20M	$56.28M
YoY Change	-85.84%	-23.76%	848.96%
TOTAL LIABILITIES
Total Short-Term Liabilities	$68.22M	$68.20M	$59.89M
Total Long-Term Liabilities	$7.971M	$80.20M	$56.28M
Total Liabilities	$148.4M	$148.4M	$165.1M
YoY Change	-10.11%	-10.12%	41.55%
SHAREHOLDERS EQUITY
Retained Earnings	-$150.8M		-$171.0M
YoY Change	-11.84%		31.3%
Common Stock	$296.8M		$226.6M
YoY Change	31.0%		27.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares			$728.5K
Shareholders Equity	$146.1M	$146.1M	$55.58M
YoY Change
Total Liabilities & Shareholders Equity	$294.5M	$294.5M	$220.7M
YoY Change	33.44%	33.44%	34.83%

Cashflow Statement

Concept	2020 Q4	2020	2019 Q4
OPERATING ACTIVITIES
Net Income	$18.50M	$17.95M	-$4.400M
YoY Change	-520.45%	-144.37%	-52.46%
Depreciation, Depletion And Amortization	$2.200M	$3.723M	$2.350M
YoY Change	-6.38%	9.89%	-66.33%
Cash From Operating Activities	$26.28M	$6.801M	-$6.400M
YoY Change	-510.62%	-120.28%	-89.34%
INVESTING ACTIVITIES
Capital Expenditures	-$8.890M	$21.15M	-$3.450M
YoY Change	157.68%	253.36%	85.48%
Acquisitions
YoY Change
Other Investing Activities	$400.0K	-$3.690M	$0.00
YoY Change
Cash From Investing Activities	-$8.480M	-$24.83M	-$3.450M
YoY Change	145.8%	298.35%	85.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$64.73M	$50.34M
YoY Change		28.58%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	30.12M	42.47M	47.07M
YoY Change	-36.01%	-46.06%	-41.92%
NET CHANGE
Cash From Operating Activities	26.28M	6.801M	-6.400M
Cash From Investing Activities	-8.480M	-24.83M	-3.450M
Cash From Financing Activities	30.12M	42.47M	47.07M
Net Change In Cash	47.92M	24.44M	37.22M
YoY Change	28.75%	-37.29%	94.26%
FREE CASH FLOW
Cash From Operating Activities	$26.28M	$6.801M	-$6.400M
Capital Expenditures	-$8.890M	$21.15M	-$3.450M
Free Cash Flow	$35.17M	-$14.34M	-$2.950M
YoY Change	-1292.2%	-63.7%	-94.93%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	18000
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	884000
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	670000
CY2019Q4	us-gaap	Assets Assets	220687000
CY2020Q4	us-gaap	Assets Assets	294494000
CY2019Q4	orgo	Deferred Acquisition Consideration Liability Current DeferredAcquisitionConsiderationLiabilityCurrent	5000000
CY2020Q4	orgo	Deferred Acquisition Consideration Liability Current DeferredAcquisitionConsiderationLiabilityCurrent	483000
CY2020Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	16666000
CY2019Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	3057000
CY2020Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	3619000
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	28387000
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	23381000
CY2019Q4	orgo	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	23450000
CY2020Q4	orgo	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	23973000
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	59894000
CY2019Q4	us-gaap	Cash Cash	60174000
CY2020Q4	us-gaap	Cash Cash	84394000
CY2019Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	196000
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	412000
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2953000
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4935000
CY2019Q4	us-gaap	Assets Current AssetsCurrent	125600000
CY2020Q4	us-gaap	Assets Current AssetsCurrent	174344000
CY2019Q4	us-gaap	Notes Receivable Related Parties Noncurrent NotesReceivableRelatedPartiesNoncurrent	556000
CY2020Q4	us-gaap	Notes Receivable Related Parties Noncurrent NotesReceivableRelatedPartiesNoncurrent	0
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	20797000
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	30622000
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	127000
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	68217000
CY2019Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	33484000
CY2020Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	10000000
CY2019Q4	orgo	Deferred Rent And Lease Incentive Obligation Noncurrent DeferredRentAndLeaseIncentiveObligationNoncurrent	1012000
CY2020Q4	orgo	Deferred Rent And Lease Incentive Obligation Noncurrent DeferredRentAndLeaseIncentiveObligationNoncurrent	2315000
CY2019Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	14431000
CY2020Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	11442000
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6649000
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7971000
CY2019Q4	us-gaap	Liabilities Liabilities	165104000
CY2020Q4	us-gaap	Liabilities Liabilities	148410000
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	10000
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	13000
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	226580000
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	299129000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-171007000
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-153058000
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	220687000
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	294494000
CY2019	us-gaap	Revenues Revenues	260981000
CY2018	us-gaap	Revenues Revenues	193449000
CY2020	us-gaap	Revenues Revenues	338298000
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	75948000
CY2018	us-gaap	Cost Of Revenue CostOfRevenue	68808000
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	87319000
CY2019	us-gaap	Gross Profit GrossProfit	185033000
CY2018	us-gaap	Gross Profit GrossProfit	124641000
CY2020	us-gaap	Gross Profit GrossProfit	250979000
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	199693000
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	161961000
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	203478000
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14799000
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10742000
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	20086000
CY2018	orgo	Write Off Of Deferred Offering Costs WriteOffOfDeferredOfferingCosts	3494000
CY2019	us-gaap	Operating Expenses OperatingExpenses	214492000
CY2018	us-gaap	Operating Expenses OperatingExpenses	176197000
CY2020	us-gaap	Operating Expenses OperatingExpenses	223564000
CY2019	us-gaap	Interest Expense InterestExpense	8996000
CY2018	us-gaap	Interest Expense InterestExpense	10789000
CY2020	us-gaap	Interest Expense InterestExpense	11279000
CY2018	orgo	Change In Fair Value Of Warrants ChangeInFairValueOfWarrants	469000
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1862000
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2095000
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10845000
CY2018	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13191000
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8936000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	150000
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	84000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	530000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	18479000
CY2018	orgo	Stock Issued During Period Value New Issue1 StockIssuedDuringPeriodValueNewIssue1	-91730000
CY2018	orgo	Stock Issued During Period Value Warrant Exercise StockIssuedDuringPeriodValueWarrantExercise	-2707000
CY2019	orgo	Stock Issued During Period Value Warrant Exercise StockIssuedDuringPeriodValueWarrantExercise	-628000
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-119000
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-269000
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-1075000
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-936000
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	-15317000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	47041000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	55583000
CY2018	orgo	Adjustments To Additional Paid In Capital Recapitalization Cost AdjustmentsToAdditionalPaidInCapitalRecapitalizationCost	-11206000
CY2018	orgo	Stock Issued During Period Value Extinguishment Of Debt StockIssuedDuringPeriodValueExtinguishmentOfDebt	-42764000
CY2019	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	46831000
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-2823000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-1661000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	146084000
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	60082000
CY2019	us-gaap	Profit Loss ProfitLoss	-40454000
CY2018	us-gaap	Profit Loss ProfitLoss	-64831000
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-201000
CY2020	us-gaap	Profit Loss ProfitLoss	17949000
CY2019	us-gaap	Depreciation Depreciation	3388000
CY2018	us-gaap	Depreciation Depreciation	3309000
CY2020	us-gaap	Depreciation Depreciation	3723000
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6043000
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3669000
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3745000
CY2019	orgo	Non Cash Interest Expense NonCashInterestExpense	243000
CY2018	orgo	Non Cash Interest Expense NonCashInterestExpense	845000
CY2020	orgo	Non Cash Interest Expense NonCashInterestExpense	236000
CY2019	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-146000
CY2018	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-1209000
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	936000
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	1075000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1661000
CY2018	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	469000
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1862000
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2095000
CY2018	orgo	Fair Value Adjustment Of Forfeiture Rights FairValueAdjustmentOfForfeitureRights	589000
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4691000
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7110000
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	18825000
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11063000
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1524000
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6700000
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	625000
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1414000
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	971000
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4700000
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-60000
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-635000
CY2019	orgo	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	2942000
CY2018	orgo	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	2354000
CY2020	orgo	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	1443000
CY2019	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-930000
CY2018	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	316000
CY2020	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-476000
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-33528000
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-60635000
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5984000
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1857000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21145000
CY2018	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1000
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	250000
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6234000
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1856000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-24833000
CY2019	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	7000000
CY2018	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	8866000
CY2020	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-23484000
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	50340000
CY2018	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	92000000
CY2019	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	17585000
CY2018	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	10000
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	269000
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	119000
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2823000
CY2019	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	628000
CY2019	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	6762000
CY2019	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1266000
CY2018	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	104000
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2427000
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	924000
CY2018	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	177000
CY2019	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2973000
CY2018	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	270000
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	78727000
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	81538000
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	42468000
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	38965000
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	19047000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	24436000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21405000
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2358000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	60370000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	84806000
CY2019	us-gaap	Interest Paid InterestPaid	8148000
CY2018	us-gaap	Interest Paid InterestPaid	5423000
CY2020	us-gaap	Interest Paid InterestPaid	9609000
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	49000
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid	8000
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	61000
CY2019	orgo	Deemed Dividends To Warrant Holders DeemedDividendsToWarrantHolders	645000
CY2019	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	537000
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	4014000
CY2018	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	172000
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2391000
CY2019	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	1099000
CY2019	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	500000
CY2019	orgo	Deferred Interest Expense DeferredInterestExpense	1446000
CY2018	orgo	Deferred Interest Expense DeferredInterestExpense	249000
CY2020	orgo	Deferred Interest Expense DeferredInterestExpense	2133000
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	111000
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	186000
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	112000
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	203000
CY2020	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	10000000
CY2019	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	50000000
CY2018	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	22680000
CY2018	orgo	Payment Of Recapitalizationcost PaymentOfRecapitalizationcost	11206000
CY2020	orgo	Payments Of Deferred Acquisition Consideration PaymentsOfDeferredAcquisitionConsideration	3517000
CY2018	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	42764000
CY2018	orgo	Fair Value Of Shares Issued In Connection With Settlement Of Investor Warrants FairValueOfSharesIssuedInConnectionWithSettlementOfInvestorWarrants	2707000
CY2018	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	1000
CY2018	orgo	Exercise Of Put Option Redeemable Common Stock ExerciseOfPutOptionRedeemableCommonStock	6762000
CY2020Q4	orgo	Working Capital WorkingCapital	106127000
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-153058000
CY2019	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	3096000
CY2020Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	63000
CY2020Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	61792000
CY2019Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	42408000
CY2020Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	16419000
CY2019Q4	us-gaap	Inventory Net InventoryNet	22918000
CY2020Q4	us-gaap	Inventory Net InventoryNet	27799000
CY2018	orgo	Inventory Reserve And Obsolence Charged To Cost Of Goods Sold InventoryReserveAndObsolenceChargedToCostOfGoodsSold	2473000
CY2020	orgo	Inventory Reserve And Obsolence Charged To Cost Of Goods Sold InventoryReserveAndObsolenceChargedToCostOfGoodsSold	3050000
CY2019	orgo	Inventory Reserve And Obsolence Charged To Cost Of Goods Sold InventoryReserveAndObsolenceChargedToCostOfGoodsSold	1297000
CY2020Q4	orgo	Prepaid Subscription PrepaidSubscription	2013000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	32830000
CY2018	orgo	Write Off Of Deferred Offering Cost WriteOffOfDeferredOfferingCost	3494000
CY2019	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	3510000
CY2020	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	4647000
CY2018	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	1923000
CY2020	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	3572000
CY2019Q4	orgo	Prepaid Subscription PrepaidSubscription	1041000
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4988000
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3049000
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	56804000
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	39359000
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3420000
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	239000
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2441000
CY2019	orgo	Allowance For Doubtful Accounts Receivable Write Offs1 AllowanceForDoubtfulAccountsReceivableWriteOffs1	-610000
CY2020	orgo	Allowance For Doubtful Accounts Receivable Write Offs1 AllowanceForDoubtfulAccountsReceivableWriteOffs1	-502000
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3049000
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4988000
CY2019Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	9178000
CY2020Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	10075000
CY2019Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	781000
CY2020Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1305000
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	12959000
CY2019Q4	us-gaap	Prepaid Advertising PrepaidAdvertising	925000
CY2020Q4	orgo	Prepaid Deposits PrepaidDeposits	1438000
CY2019Q4	orgo	Prepaid Deposits PrepaidDeposits	87000
CY2019	orgo	Reimbursement Of Offering Expenses Included In Prepaid Expenses And Other Current Assets ReimbursementOfOfferingExpensesIncludedInPrepaidExpensesAndOtherCurrentAssets	0
CY2020Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	412000
CY2019Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	900000
CY2019Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2953000
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4935000
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	87810000
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	82774000
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	69521000
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	65812000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	60068000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	47184000
CY2019Q4	us-gaap	Goodwill Goodwill	25539000
CY2020Q4	us-gaap	Goodwill Goodwill	28772000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	46400000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	15778000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	30622000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12033000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	20797000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	4949000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	4883000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	4918000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3403000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	3323000
CY2020Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	9146000
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	17640000
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	18943000
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2936000
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2059000
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	23450000
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	23973000
CY2018	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	1883000
CY2020	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	2731000
CY2019	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	2290000
CY2020Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	4786000
CY2020Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	4945000
CY2020Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	0
CY2020Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	9810000
CY2020Q4	us-gaap	Capital Leases Future Minimum Payments Net Minimum Payments1 CapitalLeasesFutureMinimumPaymentsNetMinimumPayments1	19541000
CY2020Q4	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	4480000
CY2020Q4	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	15061000
CY2020Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	3619000
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	4036000
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	3698000
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	3029000
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	34951000
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	5640000
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	3017000
CY2020Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	15531000
CY2019Q4	orgo	Accrued Legal Expenses AccruedLegalExpenses	542000
CY2020Q4	orgo	Accrued Legal Expenses AccruedLegalExpenses	150000
CY2019	orgo	Net Income Loss Attribute To Parent NetIncomeLossAttributeToParent	-41099000
CY2018	orgo	Net Income Loss Attribute To Parent NetIncomeLossAttributeToParent	-64831000
CY2020	orgo	Net Income Loss Attribute To Parent NetIncomeLossAttributeToParent	17949000
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-106000
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-105000
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	505000
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	116000
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	101000
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	19000
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	28000
CY2018	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	9000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	418000
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	39000
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-102000
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	109000
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	105000
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	212000
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	3000
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	6000
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	31783000
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	36511000
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	3342000
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	4075000
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	18000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	530000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	150000
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	84000
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	21000
CY2020Q4	us-gaap	Deferred Tax Assets Other Loss Carryforwards DeferredTaxAssetsOtherLossCarryforwards	5829000
CY2019Q4	us-gaap	Deferred Tax Assets Other Loss Carryforwards DeferredTaxAssetsOtherLossCarryforwards	4828000
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	357000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	633000
CY2020Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	2589000
CY2019Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	2528000
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	51888000
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	59017000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	48252000
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	54251000
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	18000
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	127000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.060
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.014
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.023
CY2019	orgo	Effective Income Tax Rate Reconciliation Uncertain Tax Position Reserves EffectiveIncomeTaxRateReconciliationUncertainTaxPositionReserves	-0.001
CY2018	orgo	Effective Income Tax Rate Reconciliation Uncertain Tax Position Reserves EffectiveIncomeTaxRateReconciliationUncertainTaxPositionReserves	-0.001
CY2020	orgo	Effective Income Tax Rate Reconciliation Uncertain Tax Position Reserves EffectiveIncomeTaxRateReconciliationUncertainTaxPositionReserves	0.004
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.029
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.004
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.002
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.062
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.035
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.035
CY2020	orgo	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance Federal Percent EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceFederalPercent	-0.289
CY2019	orgo	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance Federal Percent EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceFederalPercent	-0.176
CY2018	orgo	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance Federal Percent EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceFederalPercent	-0.184
CY2020	orgo	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance State Percent EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceStatePercent	-0.048
CY2019	orgo	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance State Percent EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceStatePercent	-0.039
CY2018	orgo	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance State Percent EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowanceStatePercent	-0.039
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2618000
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3286000
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3486000
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	111000
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	133000
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	157000
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	606000
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	801000
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	357000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2123000
CY2020	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	317000
CY2019	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	269000
CY2019Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	3192000
CY2018Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	3722000
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Alternative Minimum Tax DeferredTaxAssetsTaxCreditCarryforwardsAlternativeMinimumTax	106000
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	54251000
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-5999000
CY2020Q4	orgo	Operating Loss Carry Forwards Tax Credit Research OperatingLossCarryForwardsTaxCreditResearch	1003000
CY2020Q4	orgo	Operating Loss Carryforward Indefinately OperatingLossCarryforwardIndefinately	58718000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7179636
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	636043
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1476998
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6620318
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4824807
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	6274637
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.98
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.04
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.63
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.91
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.33
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.64
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	2.22
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y21D
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y2M19D
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y10M9D
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P5Y3D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	20799000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	34458000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	4749000
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	28412000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	33307000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0046
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0224
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y2M19D
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y6M
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.374
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.427
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	4.04
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	7.08
CY2020Q4	orgo	Fair Value Of Common Share FairValueOfCommonShare	3.37
CY2019Q4	orgo	Fair Value Of Common Share FairValueOfCommonShare	7.08
CY2020Q4	orgo	Shares Reserved For Issuance For Outstanding Options SharesReservedForIssuanceForOutstandingOptions	6425040
CY2019Q4	orgo	Shares Reserved For Issuance For Outstanding Options SharesReservedForIssuanceForOutstandingOptions	6503646
CY2020Q4	orgo	Shares Reserved For Issuance For Future Grant SharesReservedForIssuanceForFutureGrant	6832649
CY2019Q4	orgo	Shares Reserved For Issuance For Future Grant SharesReservedForIssuanceForFutureGrant	9008996
CY2020Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	14063737
CY2019Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	15512642
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	127731833
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-12-31
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0001661181
CY2020Q2	dei	Entity Public Float EntityPublicFloat	43300000
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	127985190
CY2020	dei	Security12b Title Security12bTitle	Class A Common Stock
CY2020	dei	Trading Symbol TradingSymbol	ORGO
CY2020	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2020	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	128460381
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	105599434
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	104870886
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	27415000
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-29459000
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-51556000
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	97000
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	13000
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	162000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-40304000
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-64747000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	17949000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-40454000
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-64831000
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	17949000
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-41099000
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-64831000
CY2018	orgo	Offering Costs OfferingCosts	270000
CY2019	orgo	Offering Costs OfferingCosts	3510000
CY2020	orgo	Offering Costs OfferingCosts	4647000
CY2018	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1157000
CY2020Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	43044000
CY2019Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	49634000
CY2020Q4	orgo	Deferred Acquisition Consideration Noncurrrent DeferredAcquisitionConsiderationNoncurrrent	1436000
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	3985000
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Use of Estimates </div></div></div></div> <div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported results of operations during the reporting periods. Actual results and outcomes may differ significantly from those estimates and assumptions. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2020	orgo	Emerginggrowthcompanypolicytextblock Emerginggrowthcompanypolicytextblock	<div style="font-family: "times new roman"; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; line-height: 12pt;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Emerging Growth Company </div></div></div></div> <div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public and private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. For example, the Company adopted ASU 2016-02, <div style="font-style:italic;display:inline;">Leases (Topic 842)</div><div style="font-style:italic;display:inline;"> on January 1</div><div style="font-style:italic;display:inline;">, 2021</div><div style="font-style:italic;display:inline;">. <div style="letter-spacing: 0px; top: 0px;;display:inline;">As a result, the Company’s financial statements may not be comparable to other public companies. The Company may take advantage of these exemptions up until December 31, 2021, or such earlier time that it is no longer an emerging growth company. It would cease to be an emerging growth company if the Company has more than $</div>1.07 <div style="letter-spacing: 0px; top: 0px;;display:inline;"> billion in annual revenue, the Company has more than $</div>700.0 <div style="letter-spacing: 0px; top: 0px;;display:inline;">million in market value of its stock held by non-affiliates or the Company issues more than $</div>1.0 <div style="letter-spacing: 0px; top: 0px;;display:inline;"> billion of non-convertible debt securities over a three-year period.</div></div> </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	107737936
CY2020	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	263000
CY2019	us-gaap	Operating Lease Expense OperatingLeaseExpense	6231000
CY2018	us-gaap	Operating Lease Expense OperatingLeaseExpense	4628000
CY2020Q3	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	13570000
CY2020	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	2246000
CY2020Q4	us-gaap	Land Subject To Ground Leases LandSubjectToGroundLeases	43850
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	1052000
CY2020Q4	orgo	Operating Lease Amount Of Minimum Rental Payments Increase In Each Year In Ten Year Option To Extend OperatingLeaseAmountOfMinimumRentalPaymentsIncreaseInEachYearInTenYearOptionToExtend	44000
CY2020Q4	orgo	Operating Lease Amount Of Minimum Rental Payments Increase In Each Year In Five Year Option To Extend OperatingLeaseAmountOfMinimumRentalPaymentsIncreaseInEachYearInFiveYearOptionToExtend	33000
CY2020Q4	us-gaap	Security Deposit SecurityDeposit	526000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	92840401
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69318456
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	111360831
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	92840401
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69318456
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.44
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.94
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.44
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.94
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1792085
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7179636
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	25727963
CY2020	orgo	Deferred Acquisition Consideration And Earnout Liability For Business Acquisition DeferredAcquisitionConsiderationAndEarnoutLiabilityForBusinessAcquisition	5218000
CY2020	us-gaap	Increase Decrease In Notes Receivable Related Parties IncreaseDecreaseInNotesReceivableRelatedParties	1516000
CY2018	orgo	Increase Decrease In Accrued Interest Of Affiliate Debt IncreaseDecreaseInAccruedInterestOfAffiliateDebt	9241000
CY2020	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	5820000
CY2018	orgo	Proceeds From Affiliates Long Term Debt ProceedsFromAffiliatesLongTermDebt	15000000
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	64729000
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	5656000
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-212000
CY2018	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-26000
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	-0.019
CY2020Q3	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	3782000
CY2020	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	7986000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6801000
CY2020Q4	us-gaap	Restructuring And Related Cost Expected Cost1 RestructuringAndRelatedCostExpectedCost1	5500000
CY2020Q4	orgo	Employee Retention Benefitsnumberofemployees EmployeeRetentionBenefitsnumberofemployees	75
CY2020Q1	orgo	Percentage Of Operatingloss Carryforwards Limitationson Use PercentageOfOperatinglossCarryforwardsLimitationsonUse	0.80
CY2020	orgo	Description Of Recognized Tax Benefits Upon Ultimate Settlement DescriptionOfRecognizedTaxBenefitsUponUltimateSettlement	The tax benefits recognized in the financial statements from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement.
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	16667000
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	20000000
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	20000000
CY2020Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	13333000
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	70000000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1553723
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	100000
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.05
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.24
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	678000
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1079000
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1438000
CY2020	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y8M23D
CY2019	orgo	Noncash Deferred Rent Expense And Lease Incentive Obligation NoncashDeferredRentExpenseAndLeaseIncentiveObligation	882000
CY2018	orgo	Noncash Deferred Rent Expense And Lease Incentive Obligation NoncashDeferredRentExpenseAndLeaseIncentiveObligation	56000
CY2020	orgo	Reimbursement Of Offering Expenses Included In Prepaid Expenses And Other Current Assets ReimbursementOfOfferingExpensesIncludedInPrepaidExpensesAndOtherCurrentAssets	1009000
CY2020Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	4979000
CY2019Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	7030000
CY2020Q4	orgo	Deferred Tax Assets Capital Leases DeferredTaxAssetsCapitalLeases	2991000
CY2019Q4	orgo	Deferred Tax Assets Capital Leases DeferredTaxAssetsCapitalLeases	3391000
CY2020Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	-3618000
CY2020Q4	orgo	Sharesreservedforissuanceforoutstandingrestrictedstockunits Sharesreservedforissuanceforoutstandingrestrictedstockunits	806048
CY2018Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	35282700
CY2018Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	17732700
CY2019Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	30890748
CY2020	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2020	dei	Entity Small Business EntitySmallBusiness	true
CY2020	orgo	Gain Loss On Deferred Acquisition Consideration Settlement GainLossOnDeferredAcquisitionConsiderationSettlement	2246000
CY2020	orgo	Adjustment For Excess And Obsolete Inventories AdjustmentForExcessAndObsoleteInventories	-3050000
CY2019	orgo	Adjustment For Excess And Obsolete Inventories AdjustmentForExcessAndObsoleteInventories	-1297000
CY2018	orgo	Adjustment For Excess And Obsolete Inventories AdjustmentForExcessAndObsoleteInventories	-2473000
CY2020	us-gaap	Repayment Of Notes Receivable From Related Parties RepaymentOfNotesReceivableFromRelatedParties	2132000
CY2020	orgo	Non Cash Or Part Non Cash Acquisition Non Cash Financial Or Equity Instrument Consideration Shares Issued NonCashOrPartNonCashAcquisitionNonCashFinancialOrEquityInstrumentConsiderationSharesIssued	7986000
CY2020	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2020	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2020	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2020Q4	orgo	Deferred Rent And Lease Incentive Obligation Current DeferredRentAndLeaseIncentiveObligationCurrent	95000
CY2020	orgo	Gain Loss On Deferred Acquisition Consideration Settlement GainLossOnDeferredAcquisitionConsiderationSettlement	2246000
CY2019	orgo	Non Cash Deemed Dividend To Warrant Holders NonCashDeemedDividendToWarrantHolders	645000
CY2020Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	2971000
CY2019Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	2874000
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	6509000
CY2020Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	2870000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	48252000
CY2020	orgo	Noncash Deferred Rent Expense And Lease Incentive Obligation NoncashDeferredRentExpenseAndLeaseIncentiveObligation	1273000
CY2019Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	-4639000
CY2020Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	618000
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.030
CY2020	orgo	Summaryofestimatedusefullivesofpropertyplantandequipmenttabletextblock Summaryofestimatedusefullivesofpropertyplantandequipmenttabletextblock	Property and equipment estimated useful lives are as follows:<table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table border="0" cellpadding="0" cellspacing="0" style="font-family: "times new roman"; font-size: 10pt; border-spacing: 0px;;margin : 0px auto;;text-align:left;;width:68%;"><tr style="font-size: 0px;"><td style="width: 52%;"></td><td style="width: 3%;;vertical-align:bottom;"></td><td style="width: 46%;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgb(204, 238, 255); width: 52%;;vertical-align:top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Leasehold improvements</div></td><td style="background-color: rgb(204, 238, 255); width: 3%;;vertical-align:bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 46%;;text-align:right;;vertical-align:top;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">Lesser of the life of the lease or the economic life of the asset</div></td></tr><tr style="font-size: 0px;"><td style="width: 52%; background-color: rgba(255, 255, 255, 0);"></td><td style="width: 3%; background-color: rgba(255, 255, 255, 0);;vertical-align:bottom;"></td><td style="background-color: rgba(255, 255, 255, 0); width: 46%;"></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="background-color: rgba(255, 255, 255, 0); width: 52%;;vertical-align:top;"><div style="text-indent: -1em; font-family: "times new roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Furniture and computers</div></div></td><td style="background-color: rgba(255, 255, 255, 0); width: 3%;;vertical-align:bottom;">  </td><td style="white-space: nowrap; background-color: rgba(255, 255, 255, 0); width: 46%;;text-align:right;;vertical-align:bottom;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">3 - 5 years</div></td></tr><tr style="font-family: times new roman; font-size: 10pt; page-break-inside: avoid;"><td style="width: 52%; background-color: rgb(204, 238, 255);;vertical-align:top;"><div style="text-indent: -1em; font-family: "times new roman"; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: "times new roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Equipmen<div style="letter-spacing: 0px; top: 0px;;display:inline;">t</div></div></div></td><td style="width: 3%; background-color: rgb(204, 238, 255);;vertical-align:bottom;">  </td><td style="white-space: nowrap; background-color: rgb(204, 238, 255); width: 46%;;text-align:right;;vertical-align:bottom;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">5 - 10 years</div></td></tr></table> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <div style="clear: both; max-height: 0px;"></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2020	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020	dei	Entity Registrant Name EntityRegistrantName	Organogenesis Holdings Inc.
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31

Files In Submission

Name	View Source	Status
0001193125-21-082849-index-headers.html	Edgar Link	pending
0001193125-21-082849-index.html	Edgar Link	pending
0001193125-21-082849.txt	Edgar Link	pending
0001193125-21-082849-xbrl.zip	Edgar Link	pending
d96488d10k.htm	Edgar Link	pending
d96488dex211.htm	Edgar Link	pending
d96488dex231.htm	Edgar Link	pending
d96488dex311.htm	Edgar Link	pending
d96488dex312.htm	Edgar Link	pending
d96488dex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
g96488g0316071241732.jpg	Edgar Link	pending
g96488g0316071241962.jpg	Edgar Link	pending
g96488g0316071242115.jpg	Edgar Link	pending
g96488g0316071242231.jpg	Edgar Link	pending
g96488g0316071242377.jpg	Edgar Link	pending
g96488g0316071242550.jpg	Edgar Link	pending
g96488g0316071242675.jpg	Edgar Link	pending
g96488g0316071242878.jpg	Edgar Link	pending
g96488g0316071243608.jpg	Edgar Link	pending
g96488g0316071243823.jpg	Edgar Link	pending
g96488g0316071244076.jpg	Edgar Link	pending
g96488g0316071244316.jpg	Edgar Link	pending
g96488g0316071244716.jpg	Edgar Link	pending
g96488g0316071245075.jpg	Edgar Link	pending
g96488g0316071245417.jpg	Edgar Link	pending
g96488g0316071245748.jpg	Edgar Link	pending
g96488g0316071246030.jpg	Edgar Link	pending
g96488g0316071246292.jpg	Edgar Link	pending
g96488g0316071246696.jpg	Edgar Link	pending
g96488g0316071247086.jpg	Edgar Link	pending
g96488g0316071247467.jpg	Edgar Link	pending
g96488g0316071247844.jpg	Edgar Link	pending
orgo-20201231.xml	Edgar Link	completed
orgo-20201231.xsd	Edgar Link	pending
orgo-20201231_cal.xml	Edgar Link	unprocessable
orgo-20201231_def.xml	Edgar Link	unprocessable
orgo-20201231_lab.xml	Edgar Link	unprocessable
orgo-20201231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ORGO
Organogenesis Holdings Inc. Stock $orgo

2020 Q4 Form 10-K Financial Statement

#000119312521082849 Filed on March 16, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORGO Organogenesis Holdings Inc. Stock $orgo

2020 Q4 Form 10-K Financial Statement

#000119312521082849 Filed on March 16, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ORGO
Organogenesis Holdings Inc. Stock $orgo